SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that it has appointed Iacob Mathiesen, Ph.D., to its Scientific Advisory Board. Dr. Mathiesen is an international expert in the field of electroporation delivery of biopharmaceuticals including DNA vaccines.
